Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Clover Health Investments, Corp. (CLOV) one of those stocks right now? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Clover Health Investments, Corp. is a member of the Medical sector. This group includes 972 individual stocks and currently holds a Zacks Sector Rank of #6. The Zacks Sector Rank co ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these ...

The Consumer Discretionary group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Imax (IMAX) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Consumer Discretionary peers, we might be able to answer that question.Imax is one of 254 companies in the Consumer Discretionary group. The Consumer Discretionary group currently sits at #10 within the Zacks Sector Rank. The Zacks ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zac ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use fundamental analysis and traditional valuation metrics to find stocks that they believe are being undervalued by the ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use fundamental analysis and ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the ...

Core Viewpoint - JPMorgan's shares reached an all-time high of $316.31, driven by optimism regarding the easing rate cycle and a strong capital return momentum, including a $50 billion buyback and a 7% dividend increase [1][10][18]. Group 1: Stock Performance - JPMorgan's stock has gained 30.4% year-to-date, outperforming the S&P Index's 14.1% increase [1]. - In comparison, Bank of America and Citigroup saw stock increases of 17.6% and 46.3%, respectively, during the same period [1]. Group 2: Net Interest Income (NII) Outlook - JPMorgan's balance sheet is highly asset-sensitive, and the anticipated Fed rate cuts may exert downward pressure on NII, projected to be $95.5 billion in 2025, reflecting over 3% year-over-year growth [5][6]. - The bank's NII recorded a five-year CAGR of 10.1%, primarily due to high-interest rates since 2022 and the acquisition of First Republic Bank [7]. - Other banks like Bank of America and Citigroup also expect modest NII declines but project growth in 2025 driven by strong loan demand [8]. Group 3: Non-Interest Income and Fee Income - Lower borrowing costs from rate cuts are expected to revive corporate financing activity, enhancing JPMorgan's advisory and underwriting fees [12]. - The bank's trading revenues are likely to benefit from increased client hedging and speculative activity due to market volatility [13]. - JPMorgan's asset management business is anticipated to see rising assets under management and higher fee revenues as markets rally [14]. Group 4: Branch Expansion and Acquisitions - JPMorgan operates 4,994 branches, the most of any U.S. bank, and plans to open 500 more by 2027 to enhance relationship banking [15][16]. - The bank has also expanded through strategic acquisitions, including a larger stake in Brazil's C6 Bank and the purchase of First Republic Bank [16]. Group 5: Financial Strength and Capital Returns - As of June 30, 2025, JPMorgan had total debt of $485.1 billion and cash and deposits of $420.3 billion, maintaining strong liquidity [17]. - The bank has consistently rewarded shareholders, increasing its quarterly dividend by 7% to $1.50 per share and authorizing a $50 billion share repurchase program [18][19]. Group 6: Asset Quality and Credit Performance - Lower interest rates are expected to improve asset quality by easing debt-service burdens, particularly benefiting variable-rate consumer and corporate loans [21]. - JPMorgan anticipates a card net charge-off rate of approximately 3.6% for 2025, indicating stable credit performance [22]. Group 7: Valuation and Earnings Estimates - JPMorgan's stock is trading at a forward P/E of 15.55X, above the industry average of 15.25X, indicating a stretched valuation [23][25]. - Earnings estimates for 2025 and 2026 have been revised upward, reflecting bullish analyst sentiments [25][26].

Key Takeaways Kinross Gold sold 36.9M Asante Gold shares for gross proceeds of C$73.1M.KGC remains a supportive investor in Asante through convertible instruments.Kinross' shares have surged 153.7% in a year, outperforming its industry.Kinross Gold Corporation (KGC) announced the sale of 36,927,650 common shares in Asante Gold Corporation at C$1.98 per share, representing roughly 5.2% of the outstanding shares.The transaction, through a private placement, generated gross proceeds of approximately C$73.1 mil ...

Key Takeaways FSI starts production for its second food-grade contract at the Illinois plant.The deal could bring $6.5M-$13M annually, scaling further through 2026.Contract includes five-year growth options and safeguards on tariffs and inflation.Flexible Solutions International, Inc. (FSI) , a developer and manufacturer of biodegradable polymers, environmentally safe water and energy conservation technologies, has announced the start of production for its second food-grade contract. This contract for the I ...